QA: Immix Biopharma Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001873835_2023_Immix_Biopharma_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001873835, Immix Biopharma Inc.

  xvar xval
0 AssetsCurrent 14,897,817
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,560
3 remainder_Assets 6,724
4 LiabilitiesCurrent 1,273,296
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 475,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,023,170
9 ResearchAndDevelopmentExpense 4,195,778
10 remainder_Expenses 10,268
11 remainder_Revenues 0
12 remainder_NetIncome -497
13 remainder_ComprehensiveNetIncome -38,387
  yvar yval
0 Assets 14,908,101
1 Liabilities 1,748,296
2 Expenses 8,229,216
3 Revenues 0
4 StockholdersEquity 13,159,805
5 NetIncome -8,229,713
6 ComprehensiveNetIncome -8,248,906
7 BaseVar 12,462,248
8 EconomicCapitalRatio 1.73

Edgar->Model Mapping

Feature Distribution

Change over Time